Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03063398 · ClinicalTrials.gov registry record
Post Acute Pancreatitis Pancreatic Exocrine Insufficiency
A clinical trial, sponsored by Ohio State University.
- Completed
- Registry status
- 196
- Enrollment target
NCT03063398: Completed study, sponsored by Ohio State University.
NCT03063398 is a clinical trial that has completed, run by Ohio State University. The registered enrollment target is 196 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03063398 has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- 196 participants
- Enrollment target
Study Summary
This study is a proposed a comprehensive prospective assessment of exocrine pancreatic insufficiency (EPI), nutritional status, and quality of life (QOL) during the early re-feeding phase, at 3 months, and 12 months following an AP attack.
Primary Outcome
Fecal elastase-1 levels EPI below 200 mcg/g stool,
Interventions
- DIAGNOSTIC_TEST No intervention, this is an observational study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 196 participants |
| Start Date | 2017-06-21 |
| Est. Completion | 2024-06-30 |
What the finished NCT03063398 record still lists
NCT03063398 is an observational study that tracks outcomes without assigning an intervention. The registered 196 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which No intervention, this is an observational study is the first listed.
NCT03063398 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03063398 about?
NCT03063398 is a clinical study titled "Post Acute Pancreatitis Pancreatic Exocrine Insufficiency". This study is a proposed a comprehensive prospective assessment of exocrine pancreatic insufficiency (EPI), nutritional status, and quality of life (QOL) during the early re-feeding phase, at 3 months, and 12 months following an AP attack.
What is the current status of trial NCT03063398?
This trial is currently completed. The enrollment target is 196 participants. The study started on 2017-06-21. Estimated completion is 2024-06-30.
What interventions are being tested in trial NCT03063398?
The interventions under investigation include: No intervention, this is an observational study (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03063398?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02822768 · 196 participants · NA
Packing Versus no Packing for Cutaneous Abscess
- NCT04250259 · 196 participants · Phase 2
SAMe Trial for Patients With Alcoholic Cirrhosis
- NCT05142592 · 196 participants · Phase 1
Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors
- NCT05317832 · 196 participants · Phase 2
Using Smartphones to Improve Physical Activity Levels of Individuals With Spinal Cord Injury
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI